BMS-309403 Catalog No.:M20293-C Smiles: CN([C@H](C)CCN1CCC(C)CC1)S(=O)(=O)C1C=C(C)C=CC=1

Smiles: CN([C@H](C)CCN1CCC(C)CC1)S(=O)(=O)C1C=C(C)C=CC=1

6-triiodobenzoic acid) for your research needs

ATPγS results in a dose-dependent effect on EBA extravasation in LPS-treated mice

The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas

FC1C=CC2=C(C=1)NC=C2CCNCC1=CC(=CC=C1)OCC(F)(F)C(F)F

BMS-309403 Catalog No.:M20293-C Smiles: CN([C@H](C)CCN1CCC(C)CC1)S(=O)(=O)C1C=C(C)C=CC=1BMS 309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS 309403 interacts with the fatty acid binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS 309403 improves endothelial function in apolipoprotein E deficient mice and in cultured human